Status
Conditions
Treatments
About
Schizophrenia affects about 0.7% of the population. Poor insight, which is common in this disease, linked to poor drug compliance is leads to rehospitalisation with major impact on quality of life. Indeed, many patients relapse with exacerbation of symptoms.
Psychoeducation can improve therapeutic alliance and medication compliance.
In this context, an individual psycho-education program (PEPITS) has been developed. PEPITS carried out by nurses during the initial stages of hospitalisation.
The hypothesis is that PEPITS program will decrease relapse and improve the compliance and insight and and so the quality of life.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Age between 18 and 65 years
Patient with a diagnosed and reported schizophrenic disorder announced :
Or a diagnosed and reported Delusional Disorder
Express written consent by the participant after receiving information about the study
Be able to communicate verbally
Participant affiliated to a social security scheme
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
200 participants in 2 patient groups
Loading...
Central trial contact
Marie LECLERC; Arnaud CHESSE
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal